Immune Checkpoint Inhibitor Therapy in Oncology Current Uses and Future Directions (JACC: CardioOncology State-of-the-Art Review December 2022)

Immune Checkpoint Inhibitor Therapy in Oncology Current Uses and Future Directions (JACC: CardioOncology State-of-the-Art Review December 2022) is organized by American College of Cardiology (ACC).,Date of Release: 20-12-2022,Term of Approval/Date of CME/MOC/ECME Expiration:19-12-2023,Description:,This review presents the current landscape of ICIs in oncology, with a focus on important aspects relevant to cardiology.